Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study

BACKGROUND: No clinical study has investigated the use of ceftazidime-avibactam combination schemes with an in vitro non-susceptible antimicrobial that could be superior to ceftazidime-avibactam monotherapy against carbapenem-resistant Klebsiella pneumoniae. METHODS: We performed a retrospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Guanhao, Zhang, Jianxin, Wang, Bei, Cai, Jiaqi, Wang, Lili, Hou, Kaixuan, Zhang, Yan, Zhang, Liang, Yang, Zhitao, He, Juan, Bian, Xiaolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322179/
https://www.ncbi.nlm.nih.gov/pubmed/34241831
http://dx.doi.org/10.1007/s40121-021-00479-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322179/
https://www.ncbi.nlm.nih.gov/pubmed/34241831
http://dx.doi.org/10.1007/s40121-021-00479-7

Ejemplares similares